Sandia Investment Management’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-589,886
Closed -$46.9K 126
2024
Q3
$46.9K Hold
589,886
0.08% 90
2024
Q2
$29.5K Sell
589,886
-20,000
-3% -$2.19K 0.04% 98
2024
Q1
$65K Sell
609,886
-566,627
-48% -$38K 0.06% 109
2023
Q4
$23.5K Sell
1,176,513
-370,224
-24% -$10K 0.02% 141
2023
Q3
$138K Hold
1,546,737
0.04% 131
2023
Q2
$72.2K Buy
1,546,737
+39,120
+3% +$1.97K 0.02% 168
2023
Q1
$53.1K Buy
1,507,617
+349,277
+30% +$19.6K 0.01% 195
2022
Q4
$44K Buy
1,158,340
+497,200
+75% +$23.6K 0.01% 192
2022
Q3
$44K Buy
661,140
+119,295
+22% +$10.8K 0.01% 222
2022
Q2
$58K Hold
541,845
0.01% 267
2022
Q1
$135K Buy
541,845
+417,698
+336% +$180K 0.02% 240
2021
Q4
$98K Buy
+124,147
New +$91K 0.02% 234

Other funds holding COCHW

Sandia Investment Management's COCHW Position: Q4 2025 in Review

Sandia Investment Management reduced its Envoy Medical Warrant (COCHW) stake by 13% in Q4 2025, selling an estimated $3.5K and leaving 514,702 shares worth $20K. The position accounts for 0.05% of the portfolio, ranked #115.

Sandia Investment Management first reported a position in COCHW in Q4 2024 and has held it in 5 quarters since. The position peaked at $27.5K in Q4 2024. 35 funds tracked by Wall St. Rank hold COCHW as of Q4 2025.

  • Sandia Investment Management held 514,702 shares of Envoy Medical Warrant worth $20K as of Q4 2025.
  • Sandia Investment Management sold 75,184 Envoy Medical Warrant shares in Q4 2025, an estimated $3.5K.
  • Envoy Medical Warrant made up 0.05% of Sandia Investment Management's portfolio in Q4 2025, its #115 holding.
  • Sandia Investment Management first reported a position in Envoy Medical Warrant in Q4 2024 and has held it in 5 quarters since.
  • Sandia Investment Management's Envoy Medical Warrant position peaked at $27.5K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q4 2025.

Based on Sandia Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.